55 results
Page 2 of 3
8-K
EX-99.1
egb2z906
16 Dec 21
China NMPA Approves NUZYRA® as a Category 1
7:43am
8-K
2s4pc8o89wb pp2
16 Dec 21
China NMPA Approves NUZYRA® as a Category 1
7:43am
8-K
EX-99.3
seyqvcd w2fr
9 Nov 21
Zai Lab and Blueprint Medicines Announce Strategic Collaboration and License
4:26pm
8-K
EX-99.1
qotfw1kj qo6rc
9 Aug 21
Zai Lab Announces Second Quarter 2021
4:06pm
10-Q
EX-10.1
goow wvc9n5
10 May 21
Quarterly report
8:58am
10-Q
EX-10.2
lgn76vunfn 4tde4s
10 May 21
Quarterly report
8:58am
8-K
EX-99.1
befxm xfx
10 May 21
Zai Lab Reports First Quarter 2021 Financial Results
8:55am
DEF 14A
ypqnt4snk6bcv7ktb48
30 Apr 21
Definitive proxy
4:02pm
424B5
1o4m35
21 Apr 21
Prospectus supplement for primary offering
4:45pm
424B5
5k88po7bnk1unbqh753
19 Apr 21
Prospectus supplement for primary offering
4:57pm
PRE 14A
xnwbr5ur0oi 6ss4u6
14 Apr 21
Preliminary proxy
4:00pm
8-K
EX-99.1
478g99snfyq fb3wm
31 Mar 21
China NMPA Approves QINLOCK® (Ripretinib) for Treatment of Advanced Gastrointestinal Stromal
7:32am
8-K
EX-99.1
303qxwe4np90et
1 Mar 21
Zai Lab Announces Financial Results
7:01am
10-K
EX-10.21
ccyn1c8
1 Mar 21
Annual report
12:00am
10-K
pbylnbfuqe1n1z
1 Mar 21
Annual report
12:00am
10-K
EX-10.33
iit9tdge
1 Mar 21
Annual report
12:00am
10-K
EX-10.22
b2ix xd4qrix6kbznu
1 Mar 21
Annual report
12:00am
6-K
EX-99.1
hv6l14o9 gbd60f
1 Dec 20
Zai Lab Appoints Alan Sandler, M.D., as President, Head of Global Development, Oncology
7:30am